Towards Healthcare
Europe Biotechnology Market to Grow at 11.30% CAGR till 2034

Europe Biotechnology Market Thrives with Gene Editing and Biopharma

Market insights predict, the Europe biotechnology industry is expected to grow from USD 418.76 billion in 2024 to USD 1208.75 billion by 2034, driven by a CAGR of 11.30%. The presence of a robust biotech hub is driving the Europe biotechnology market. Germany led the market due to the increased investment in infrastructure.

  • Last Updated: 07 October 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2023
  • Base Year: 2024
  • Estimated Years: 2025-2034

About The Author

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology, and healthcare services.

She began her research career at Precedence Research, where she contributed to a wide range of healthcare industry studies, helping build a strong foundation in market intelligence and strategic research. Currently, Deepa plays a critical role at Towards Healthcare, while also extending her research capabilities across Statifacts, supporting cross-industry intelligence initiatives with a focus on healthcare.

Her ability to distill complexity into clarity has made her a trusted contributor to both internal teams and external clients across the healthcare value chain. By combining professionalism with an evolving depth in healthcare research, Deepa consistently adds value to projects that demand critical thinking, market precision, and industry-specific knowledge. Her contributions help organizations navigate the complexities of regulated markets and make data-backed growth decisions.

FAQ's

The Europe biotechnology market stands at USD 465.87 billion in 2025 and is expected to reach USD 1208.75 billion by 2034, growing at a CAGR of 11.30% from 2024 to 2034.

Germany is currently leading the Europe biotechnology market share 22% due to the broader investment in R&D and government support.

The Europe biotechnology market includes 5 segments, such as by product/service, by technology, by application, by end user, and by country.

Specialty Pharmaceuticals, Medical Biotechnology, Infection Control, and Digitalization & AI are the main areas of focus for Nordic biotech.

EMA, EFSA, GOVERNMENT.NI, UKRI, ERACoBiotech, ICGEB, EU.